Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis
Open Access
- 1 January 2013
- journal article
- research article
- Published by Hindawi Limited in Evidence-Based Complementary and Alternative Medicine
- Vol. 2013, 1-12
- https://doi.org/10.1155/2013/247504
Abstract
Ellagitannins (ETs) from pomegranate juice (PJ) are bioactive polyphenols with chemopreventive potential against prostate cancer (PCa). ETs are not absorbed intact but are partially hydrolyzed in the gut to ellagic acid (EA). Colonic microflora can convert EA to urolithin A (UA), and EA and UA enter the circulation after PJ consumption. Here, we studied the effects of EA and UA on cell proliferation, cell cycle, and apoptosis in DU-145 and PC-3 androgen-independent PCa cells and whether combinations of EA and UA affected cell proliferation. EA demonstrated greater dose-dependent antiproliferative effects in both cell lines compared to UA. EA induced cell cycle arrest in S phase associated with decreased cyclin B1 and cyclin D1 levels. UA induced a G2/M arrest and increased cyclin B1 and cdc2 phosphorylation at tyrosine-15, suggesting inactivation of the cyclin B1/cdc2 kinase complex. EA induced apoptosis in both cell lines, while UA had a less pronounced proapoptotic effect only in DU-145. Cotreatment with low concentrations of EA and UA dramatically decreased cell proliferation, exhibiting synergism in PC-3 cells evaluated by isobolographic analysis and combination index. These data provide information on pomegranate metabolites for the prevention of PCa recurrence, supporting the role of gut flora-derived metabolites for cancer prevention.Keywords
Funding Information
- Fondazione Roma Sapienza
This publication has 61 references indexed in Scilit:
- Pomegranate juice and specific components inhibit cell and molecular processes critical for metastasis of breast cancerBreast Cancer Research and Treatment, 2012
- Equol an isoflavonoid: potential for improved prostate health, in vitro and in vivoevidenceReproductive Biology and Endocrinology, 2011
- Three Observations That Have Changed Our Understanding of Cyclin D1 and p27Kip1 in Cell Cycle ControlGenes & Cancer, 2010
- Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapyMolecular Cancer, 2009
- Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptorThe Journal of Nutritional Biochemistry, 2008
- Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-κB-dependent mechanismMolecular Cancer Therapeutics, 2008
- Pomegranate Juice and Extracts Provide Similar Levels of Plasma and Urinary Ellagitannin Metabolites in Human SubjectsJournal of Medicinal Food, 2008
- AR, the cell cycle, and prostate cancerNuclear Receptor Signaling, 2008
- Ellagic acid induces apoptosis through inhibition of nuclear factor kB in pancreatic cancer cellsWorld Journal of Gastroenterology, 2008
- The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionMolecular Cancer, 2007